NCT00713882

Brief Summary

The aims and objectives of this research are to identify chronic health conditions, psychological disease, quality of life issues, and patient preferences for survivorship care in patients who have survived aggressive lymphoma. Subjects will be asked to participate in an oral interview with the primary investigator, either in-person or over the telephone. It is estimated that the survey will take about an hour.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2008

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 7, 2008

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 14, 2008

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
Last Updated

March 12, 2009

Status Verified

March 1, 2009

Enrollment Period

7 months

First QC Date

July 7, 2008

Last Update Submit

March 10, 2009

Conditions

Lymphoma, Non-HodgkinsHodgkins Disease

Keywords

SurvivorsQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Quality of life

    cross-sectional (time of interview)

Study Arms (1)

Observational

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be identified via physician referral at Weill Cornell Medical College, Hematology-Oncology outpatient clinic, or self-referral.

You may qualify if:

  • adults who have been treated for either aggressive lymphoma (Hodgkins lymphoma, diffuse large B-cell lymphoma, follicular grade III NHL, or others)
  • are greater than 2 years from the time of last treatment
  • no known active cancer

You may not qualify if:

  • unable to participate in an interview in English
  • indolent lymphoma (i.e. non-curable, including follicular grades 1-2 NHL)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medical College

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Lymphoma, Non-HodgkinHodgkin Disease

Condition Hierarchy (Ancestors)

LymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Carrie A Thompson, M.D.

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 7, 2008

First Posted

July 14, 2008

Study Start

April 1, 2008

Primary Completion

November 1, 2008

Study Completion

November 1, 2008

Last Updated

March 12, 2009

Record last verified: 2009-03

Locations

US(1)